Elevation Oncology price target lowered to $1 from $6 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Elevation Oncology (ELEV) to $1 from $6 and keeps a Buy rating on the shares after the ...
Taiwan News2d
GCC Basmati Rice Market to Reach USD 2.92 Billion by 2028, Growing at a 5.9% CAGR
South Asian expatriates’ high and wide presence across GCC (Gulf Cooperation Council) countries, increasing demand for better quality rice, and foreign investments in rice imports could drive GCC ...
Elevation Oncology downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Elevation Oncology (ELEV) to Market Perform from Outperform with a price target of $1, down from $9, after the company ...
Colgate-Palmolive: A Defensive Stock With Growth Potential
Colgate-Palmolive's strong Latin American demand faces US dollar challenges. Learn why CL stock remains a good buy with ...